BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32003167)

  • 1. [Aberrant expression of arrestin-1 and recoverin in kidney tumors].
    Tsoy LV; Korolev DO; Vinarov AZ; Enikeev ME; Lerner YV; Tsarichenko DG; Popov NA; Abdusalamov AF; Gorobets YP; Demidko YL; Varshavskiy VA; Zamyatnin AA; Rapoport LM
    Urologiia; 2019 Dec; (6):48-53. PubMed ID: 32003167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma.
    Baldin AV; Grishina AN; Korolev DO; Kuznetsova EB; Golovastova MO; Kalpinskiy AS; Alekseev BY; Kaprin AD; Zinchenko DV; Savvateeva LV; Varshavsky VA; Zernii EY; Vinarov AZ; Bazhin AV; Philippov PP; Zamyatnin AA
    Biochimie; 2019 Feb; 157():26-37. PubMed ID: 30389514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Invasive Diagnostics of Renal Cell Carcinoma Using Ultrasensitive Immunodetection of Cancer-Retina Antigens.
    Shlyapnikov YM; Malakhova EA; Potoldykova NV; Svetocheva YA; Vinarov AZ; Zinchenko DV; Zernii EY; Zamyatnin AA; Shlyapnikova EA
    Biochemistry (Mosc); 2022 Jul; 87(7):658-666. PubMed ID: 36154884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cancer-retina antigen recoverin as a potential biomarker for renal tumors.
    Golovastova MO; Tsoy LV; Bocharnikova AV; Korolev DO; Gancharova OS; Alekseeva EA; Kuznetsova EB; Savvateeva LV; Skorikova EE; Strelnikov VV; Varshavsky VA; Vinarov AZ; Nikolenko VN; Glybochko PV; Zernii EY; Zamyatnin AA; Bazhin AV; Philippov PP
    Tumour Biol; 2016 Jul; 37(7):9899-907. PubMed ID: 26813565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
    Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
    Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'.
    McGregor DK; Khurana KK; Cao C; Tsao CC; Ayala G; Krishnan B; Ro JY; Lechago J; Truong LD
    Am J Surg Pathol; 2001 Dec; 25(12):1485-92. PubMed ID: 11717537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
    Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
    Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.
    Kinouchi T; Uemura M; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Matsuzaki K; Nakata W; Yoshida T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Cancer Sci; 2017 Dec; 108(12):2495-2502. PubMed ID: 28985012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.
    Zhang KJ; Wilson GD; Kara S; Majeske A; Zhang PL; Hafron JM
    Int Urol Nephrol; 2019 Nov; 51(11):1893-1902. PubMed ID: 31385177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
    Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA
    Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
    Yap NY; Yap FN; Perumal K; Rajandram R
    Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
    [No Abstract]   [Full Text] [Related]  

  • 14. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
    Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
    Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis.
    Zhang L; Jiang H; Xu G; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y
    Mol Med Rep; 2015 Jun; 11(6):4093-100. PubMed ID: 25673070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
    Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
    Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review.
    McCroskey Z; Sim SJ; Selzman AA; Ayala AG; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():32-36. PubMed ID: 28807339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.